|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.990 CNY | +0.81% |
|
-3.11% | -2.54% |
| 07-29 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
Company Valuation: Jointown Pharmaceutical Group Co., Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,919 | 24,052 | 26,691 | 25,148 | 25,531 | 24,882 | - | - |
| Change | - | -10.65% | 10.97% | -5.78% | 1.52% | -2.54% | - | - |
| Enterprise Value (EV) 1 | 29,021 | 21,882 | 24,319 | 20,414 | 20,954 | 20,561 | 19,839 | 19,813 |
| Change | - | -24.6% | 11.14% | -16.06% | 2.65% | -1.87% | -3.51% | -0.13% |
| P/E | 11.6x | 12.2x | 12.7x | 10.2x | 11.6x | 10.8x | 10x | 9.14x |
| PBR | 1.31x | 1.09x | 1.14x | 0.95x | 0.96x | 0.84x | 0.8x | 0.77x |
| PEG | - | -0.8x | 1.76x | 0.6x | -1x | 2.08x | 1.29x | 0.96x |
| Capitalization / Revenue | 0.22x | 0.17x | 0.18x | 0.17x | 0.16x | 0.15x | 0.14x | 0.13x |
| EV / Revenue | 0.24x | 0.16x | 0.16x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x |
| EV / EBITDA | 6.93x | 6.21x | 6.5x | 4.61x | 5.18x | 4.42x | 3.79x | 3.27x |
| EV / EBIT | 8.08x | 7.67x | 8.05x | 5.62x | 6.34x | 5.79x | 5.17x | 4.66x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2 | 0.2088 | 0.2228 | 0.2503 |
| Rate of return | 2.04% | 3.83% | 3.57% | 3.91% | 3.91% | 4.19% | 4.46% | 5.02% |
| EPS 2 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.44 | 0.4628 | 0.4986 | 0.5459 |
| Distribution rate | 23.6% | 46.7% | 45.5% | 40% | 45.5% | 45.1% | 44.7% | 45.8% |
| Net sales 1 | 122,407 | 140,424 | 150,140 | 151,810 | 161,390 | 169,796 | 178,379 | 185,219 |
| EBITDA 1 | 4,187 | 3,526 | 3,741 | 4,427 | 4,046 | 4,653 | 5,241 | 6,066 |
| EBIT 1 | 3,593 | 2,853 | 3,023 | 3,635 | 3,306 | 3,554 | 3,839 | 4,247 |
| Net income 1 | 2,448 | 2,085 | 2,174 | 2,507 | 2,255 | 2,329 | 2,517 | 2,744 |
| Net Debt 1 | 2,102 | -2,170 | -2,372 | -4,734 | -4,576 | -4,321 | -5,043 | -5,070 |
| Reference price 2 | 5.470 | 4.846 | 5.434 | 5.120 | 5.120 | 4.990 | 4.990 | 4.990 |
| Nbr of stocks (in thousands) | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | 4,986,434 | - | - |
| Announcement Date | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | 4/27/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.78x | 0.12x | 4.42x | 4.19% | 3.69B | ||
| 22.26x | 0.24x | 14.04x | 0.41% | 101B | ||
| 33.28x | 0.24x | 15.22x | 0.87% | 55.37B | ||
| 46.71x | 3.29x | 30.57x | 1.33% | 24.21B | ||
| 11.75x | 0.2x | 5x | 2.59% | 8.29B | ||
| 13.08x | 0.99x | 8x | 2.58% | 7.53B | ||
| 5.94x | 0.1x | 2.73x | 4.98% | 6.75B | ||
| 9.09x | 1.71x | 5.45x | 3.62% | 6.19B | ||
| 24.32x | 1.1x | 13.79x | 3.11% | 5.07B | ||
| 13.54x | - | - | 2.4% | 3.68B | ||
| Average | 19.08x | 0.89x | 11.02x | 2.61% | 22.22B | |
| Weighted average by Cap. | 25.82x | 0.66x | 14.86x | 1.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600998 Stock
- Valuation Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions
















